What Happens When FDA Comes to Your Facility
FDA facility inspections are a real possibility for hemp operators manufacturing food, beverage, or dietary supplement products, and understanding the process helps operators prepare appropriately rather than treating it as an abstract regulatory concern.
Types of FDA Inspections
Routine surveillance inspections. Periodic inspections conducted as part of FDA's general oversight, not triggered by a specific complaint or issue, though frequency varies based on facility risk classification and FDA's resource allocation.
For-cause inspections. Triggered by a specific complaint, reported adverse event, or other information suggesting a potential compliance issue at a specific facility.
Pre-approval inspections. Less common for hemp products specifically but relevant if a facility is seeking specific regulatory approvals requiring inspection as part of the process.
What Inspectors Typically Review
FDA inspectors evaluate compliance with GMP requirements discussed elsewhere in this publication, reviewing facility conditions, equipment maintenance and calibration records, personnel training documentation, batch production records for specific production runs, quality control procedures and their actual implementation (not just written policy), and complaint handling and investigation records.
How Inspections Typically Proceed
Notice and initial meeting. Inspections may be announced in advance or, particularly for for-cause inspections, may occur with minimal or no advance notice. The inspection typically begins with an opening meeting explaining the inspection's scope.
Facility walkthrough and document review. Inspectors tour the facility and review requested documentation, often over multiple days depending on facility size and inspection scope.
Observations and Form 483. If inspectors identify potential violations, they document these as observations, formally communicated via FDA Form 483 at the inspection's conclusion.
Response and follow-up. Facilities receiving a Form 483 typically have an opportunity to respond with corrective action plans, and FDA may conduct follow-up inspections to verify corrections were implemented.
How to Prepare for a Potential Inspection
Maintain audit-ready documentation continuously. The self-audit practices discussed elsewhere in this publication directly support inspection readiness, since documentation gaps discovered during an actual inspection are far more consequential than gaps found during your own review.
Designate an inspection response team. Know in advance who manages inspector interactions, document requests, and communication during an actual inspection, rather than figuring this out during the inspection itself.
Conduct mock inspections. Some facilities benefit from periodic internal mock inspections, applying the same scrutiny an actual FDA inspector would, to identify gaps before a real inspection does.
What Happens After a Form 483 or Warning Letter
Timely, thorough corrective action is critical. FDA's continued enforcement posture depends significantly on whether a facility demonstrates genuine commitment to addressing identified issues, not just formal acknowledgment of the observations.
Low Gravity Hemp maintains inspection-ready documentation and quality systems designed to withstand regulatory scrutiny. Contact us to learn more about our compliance and quality assurance practices.
